Skip to main content
. Author manuscript; available in PMC: 2009 Feb 1.
Published in final edited form as: Res Nurs Health. 2008 Feb;31(1):42–51. doi: 10.1002/nur.20232

Table 4.

ANCOVA of Potentially Inappropriate Medication (PIM) Status on Log of the Cost or Utilization Variable Controlling for Sex, Age, Charlson Comorbidity Index (CCI); total Number of Prescription Types

Model R2 Back Transformed Adjusted Mean SE F-value p-value
Total paid costs .21
 Female sex 21.18 <.01
 Age 2.68 .10
 CCI 2,761.93 <.01
 PIM status 522.19 <.01
  0 PIMs (n=10,002) 174.94 1.02
  1 PIM (n=4,549) 381.36 1.03
  2+ PIMs (n=2,326) 635.36 1.04
Facility paid costs .16
 Female sex 73.15 <.01
 Age .02 .89
 CCI 2,235.74 <.01
 PIM status 232.78 <.01
  0 PIMs (n=10,002) 11.84 1.03
  1 PIM (n=4,549) 23.15 1.05
  2+ PIMs (n=2,326) 52.45 1.07
Provider paid costs .17
 Female sex 28.63 <.01
 Age 1.38 .23
 CCI 2,569.81 <.01
 PIM status 219.52 <.01
  0 PIMs (n=10,002) 30.80 1.02
  1 PIM (n=4,549) 51.01 1.03
  2+ PIMs (n=2,326) 85.62 1.05
Prescription paid costs .12
 Female sex 7.75 .01
 Age .57 .45
 CCI 476.67 <.01
 PIM status 744.38 <.01
  0 PIMs (n=10,002) 25.49 1.02
  1 PIM (n=4,549) 73.42 1.03
  2+ PIMs (n=2,326) 121.51 1.04
Inpatient visits .09
 Female sex 7.24 .01
 Age 3.29 .07
 CCI 1,438.39 <.01
 PIM status 34.48 <.01
  0 PIMs (n=10,002) 1.02 1.00
  1 PIM (n=4,549) 1.03 1.00
  2+ PIMs (n=2,326) 1.04 1.00
Outpatient visits .10
 Female sex 56.48 <.01
 Age 39.28 <.01
 CCI 1,455.36 <.01
 PIM status 106.66 <.01
  0 PIMs (n=10,002) 1.12 1.00
  1 PIM (n=4,549) 1.18 1.01
  2+ PIMs (n=2,326) 1.26 1.01
Office visits .18
 Female sex 5.06 .03
 Age 15.96 <.01
 CCI 2,298.24 <.01
 PIM status 438.46 <.01
  0 PIMs (n=10,002) 3.29 1.01
  1 PIM (n=4,549) 4.23 1.01
  2+ PIMs (n=2,326) 5.36 1.02
Emergency room visits .02
 Female sex 1.24 .27
 Age 21.34 <.01
 CCI 112.77 <.01
 PIM status 65.48 <.01
  0 PIMs (n=10,002) 1.01 1.00
  1 PIM (n=4,549) 1.01 1.00
  2+ PIMs (n=2,326) 1.04 1.00

CCI, Charlson co-morbidity index, PIM, potentially inappropriate medication.